| Endocytosis of nanomedicines G Sahay, DY Alakhova, AV Kabanov Journal of controlled release 145 (3), 182-195, 2010 | 2348 | 2010 |
| Pluronics and MDR reversal: an update DY Alakhova, AV Kabanov Molecular pharmaceutics 11 (8), 2566-2578, 2014 | 240 | 2014 |
| Structure-property relationship in cytotoxicity and cell uptake of poly (2-oxazoline) amphiphiles R Luxenhofer, G Sahay, A Schulz, D Alakhova, TK Bronich, R Jordan, ... Journal of Controlled Release 153 (1), 73-82, 2011 | 219 | 2011 |
| A high capacity polymeric micelle of paclitaxel: Implication of high dose drug therapy to safety and in vivo anti-cancer activity Z He, X Wan, A Schulz, H Bludau, MA Dobrovolskaia, ST Stern, ... Biomaterials 101, 296-309, 2016 | 182 | 2016 |
| Differential metabolic responses to pluronic in MDR and non-MDR cells: a novel pathway for chemosensitization of drug resistant cancers DY Alakhova, NY Rapoport, EV Batrakova, AA Timoshin, S Li, D Nicholls, ... Journal of Controlled Release 142 (1), 89-100, 2010 | 171 | 2010 |
| Can nanomedicines kill cancer stem cells? Y Zhao, DY Alakhova, AV Kabanov Advanced drug delivery reviews 65 (13-14), 1763-1783, 2013 | 132 | 2013 |
| A simple way to enhance Doxil® therapy: drug release from liposomes at the tumor site by amphiphilic block copolymer Y Zhao, DY Alakhova, JO Kim, TK Bronich, AV Kabanov Journal of controlled release 168 (1), 61-69, 2013 | 132 | 2013 |
| Poly (2-oxazoline) based micelles with high capacity for 3rd generation taxoids: Preparation, in vitro and in vivo evaluation Z He, A Schulz, X Wan, J Seitz, H Bludau, DY Alakhova, DB Darr, ... Journal of controlled release 208, 67-75, 2015 | 109 | 2015 |
| Effect of doxorubicin/pluronic SP1049C on tumorigenicity, aggressiveness, DNA methylation and stem cell markers in murine leukemia DY Alakhova, Y Zhao, S Li, AV Kabanov PloS one 8 (8), e72238, 2013 | 98 | 2013 |
| Alteration of genomic responses to doxorubicin and prevention of MDR in breast cancer cells by a polymer excipient: pluronic P85 EV Batrakova, DL Kelly, S Li, Y Li, Z Yang, L Xiao, DY Alakhova, ... Molecular pharmaceutics 3 (2), 113-123, 2006 | 95 | 2006 |
| Eradication of cancer stem cells in triple negative breast cancer using doxorubicin/pluronic polymeric micelles Y Zhao, DY Alakhova, X Zhao, V Band, EV Batrakova, AV Kabanov Nanomedicine: Nanotechnology, Biology and Medicine 24, 102124, 2020 | 56 | 2020 |
| Fast path message transfer agent B Taylor US Patent 7,487,212, 2009 | 29 | 2009 |
| Effect of pluronic p85 on amino acid transport in bovine brain microvessel endothelial cells X Zhang, DY Alakhova, EV Batrakova, S Li, Z Yang, Y Li, AV Kabanov Journal of Neuroimmune Pharmacology 4, 35-46, 2009 | 19 | 2009 |
| Horizontal gene transfer from macrophages to ischemic muscles upon delivery of naked DNA with Pluronic block copolymers V Mahajan, Z Gaymalov, D Alakhova, R Gupta, IH Zucker, AV Kabanov Biomaterials 75, 58-70, 2016 | 15 | 2016 |
| Pluronic block copolymers enhance the anti-myeloma activity of proteasome inhibitors H Hu, A Petrosyan, NA Osna, T Liu, AA Olou, DY Alakhova, PK Singh, ... Journal of controlled release 306, 149-164, 2019 | 7 | 2019 |
| Nanomedicine and nanotechnology are rapidly developing fields across the nation and worldwide. DY Alakhova, AV Kabanov Journal of controlled release: official journal of the Controlled Release …, 2015 | 4 | 2015 |
| Drug Delivery in Oncology. From Basic Research to Cancer Therapy. 3 Volumes. Edited by Felix Kratz, Peter Senter and Henning Steinhagen. DY Alakhova, AY Kabanov Angewandte Chemie International Edition 53 (14), 2014 | 3 | 2014 |
| Endocytosis of nanomedicines DY Alakhova, G Sahay, AV Kabanov Journal of Controlled Release 145 (3), 182-195, 2010 | 1 | 2010 |
| Compositions and methods for the treatment of cancer AV Kabanov, DY Alakhova, Y Zhao US Patent 10,022,325, 2018 | | 2018 |
| Data on macrophage mediated muscle transfection upon delivery of naked plasmid DNA with block copolymers V Mahajan, Z Gaymalov, D Alakhova, R Gupta, IH Zucker, AV Kabanov Data in brief 7, 1269-1282, 2016 | | 2016 |
Alexander KabanovProfessor, University of North Carolina Chapel HillVerified email at email.unc.edu
